PHARMACYCLICS INC (PCYC) [Rocket]

In millions, except per share items	Dec-31-14	Dec-31-13	Dec-31-12	Jun-30-12	Jun-30-11	Apr-19-11	Jun-30-10	Jun-30-09
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Product revenues	492.4	13.6
Other	237.3	246.6
Revenues [+]	729.7	260.2	160.7	82.0	8.2		9.3	14.0
Royalties							17.4
Products	492.4	13.6
Revenue growth [+]	180.5%	61.9%		895.9%	-11.5%		-33.3%
Product revenues	3527.9%
Cost of goods sold	40.4	3.5	-47.5	-54.5	-34.5		-32.5	8.5
Gross profit	689.3	256.7	208.1	136.5	42.7		41.8	5.5
Gross margin	94.5%	98.7%	129.5%	166.5%	518.8%		449.0%	39.3%
Selling, general and administrative [+]	168.0	104.0	12.1	15.6	9.1		15.1	8.5
General and administrative							15.1	8.5
Research and development	344.9	256.0	76.0	109.1	69.0		17.4
Other operating expenses	54.1	-201.3					24.9	19.4
EBITDA [+]	126.8	100.1	120.6	12.4	-35.1		-15.4	-22.1
EBITDA growth	26.6%	-17.0%		-135.5%	128.1%		-30.5%	-12.1%
EBITDA margin	17.4%	38.5%	75.1%	15.2%	-426.1%		-165.2%	-158.6%
Depreciation and amortization	3.9	2.2	0.6	0.6	0.3		0.2	0.3
EBITA	122.9	97.9	120.1	11.9	-35.4		-15.6	-22.4
EBITA margin	16.8%	37.6%	74.7%	14.5%	-429.7%		-167.7%	-160.7%
Amortization of intangibles	0.5
EBIT [+]	122.4	97.9	120.1	11.9	-35.4		-15.6	-22.4
EBIT growth	25.0%	-18.4%		-133.6%	126.6%		-30.4%	-12.1%
EBIT margin	16.8%	37.6%	74.7%	14.5%	-429.7%		-167.7%	-160.7%
Interest income	0.4	0.3	0.1	0.2	0.2		0.1	0.1
Interest income	0.4	0.3	0.1	0.2	0.2		0.1	0.1
Other income (expense), net	-0.4	-0.1	0.0	0.0	0.0		0.0	-0.6
Pre-tax income	122.4	98.1	120.2	12.0	-35.2		-15.6	-22.9
Income taxes	36.3	31.1	2.6	0.0	0.0		-0.6	0.6
Tax rate	29.7%	31.7%	2.2%	0.3%	0.0%		3.5%
Net income	86.1	67.0	117.5	12.0	-35.2		-15.0	-23.4
Net margin	11.8%	25.8%	73.2%	14.6%	-427.6%		-161.4%	-168.0%

Basic EPS [+]	$1.14	$0.92	$1.69	$0.17	($0.59)		($0.31)	($0.88)
Growth	24.3%	-45.4%		-129.7%	88.9%		-64.8%	-5.6%
Diluted EPS [+]	$1.10	$0.87	$1.58	$0.17	($0.59)		($0.31)	($0.88)
Growth	26.8%	-45.0%		-128.1%	88.9%		-64.8%	-5.6%

Shares outstanding (basic) [+]	75.2	72.8	69.7	68.7	60.0		48.3	26.6
Growth	3.4%	4.5%		14.6%	24.1%		81.9%	2.2%
Shares outstanding (diluted) [+]	78.2	77.1	74.4	72.6	60.0		48.3	26.6
Growth	1.4%	3.6%		21.1%	24.1%		81.9%	2.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.